SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy
Inhibition of the NEDD8-activating enzyme (NAE), the key E1 enzyme in the neddylation cascade, has been considered an attractive anticancer strategy with the discovery of the first-in-class NAE inhibitor, MLN4924. In this study, we identified SOMCL-19-133 as a highly potent, selective, and orally av...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2022-10-01
|
| Col·lecció: | Neoplasia: An International Journal for Oncology Research |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1476558622000501 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|